The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.
暂无分享,去创建一个
H J Alter | R H Purcell | R. Purcell | P. Farci | A. Balestrieri | H. Alter | A. Balestrieri | D Y Chien | G. Diaz | A Balestrieri | P Farci | A Shimoda | A Coiana | G Diaz | G Peddis | J C Melpolder | A Strazzera | S J Munoz | D. Chien | J. Melpolder | A. Shimoda | G. Peddis | D. Chien | A. Strazzera | A. Coiana | S. Munoz
[1] A Cerino,et al. Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross‐reactivity and immune‐mediated sequence variation , 1999, Hepatology.
[2] A. Prince,et al. Immunity in hepatitis C infection. , 1992, The Journal of infectious diseases.
[3] T. Santantonio,et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.
[4] J. Holland,et al. Rapid evolution of RNA viruses. , 1987, Annual review of microbiology.
[5] O. Laeyendecker,et al. Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy , 1999, Journal of Virology.
[6] N. Ogata,et al. Lack of protective immunity against reinfection with hepatitis C virus , 1992 .
[7] R. Purcell,et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. , 1986, Annals of internal medicine.
[8] B. L. Welch. THE SIGNIFICANCE OF THE DIFFERENCE BETWEEN TWO MEANS WHEN THE POPULATION VARIANCES ARE UNEQUAL , 1938 .
[9] N. Kato,et al. Hypervariable regions in the putative glycoprotein of hepatitis C virus. , 1991, Biochemical and biophysical research communications.
[10] Matthew J. Brauer,et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. , 1991, Virology.
[11] M. Sakamoto,et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. , 1993, Virology.
[12] C. Ferrari,et al. T‐cell response to structural and nonstructural hepatitis C virus antigens in persistent and self‐limited hepatitis C virus infections , 1994, Hepatology.
[13] A. Weiner,et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution , 1992, Journal of virology.
[14] K. Ishak,et al. Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis , 1991, Hepatology.
[15] N. Kato,et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus , 1993, Journal of virology.
[16] P Parham,et al. Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.
[17] Steven M. Wolinsky,et al. Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.
[18] S. Kwok,et al. Avoiding false positives with PCR , 1989, Nature.
[19] S. Wain-Hobson. Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. , 1992, Current topics in microbiology and immunology.
[20] R. Purcell,et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. , 1996, Virology.
[21] R. Purcell,et al. Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee. , 1999, The Journal of infectious diseases.
[22] M. Houghton,et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Schreier,et al. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. , 1995, Virology.
[24] M. Shapiro,et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Purcell,et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. , 1991, The New England journal of medicine.
[26] M. Massari,et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.
[27] F. Iber,et al. Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis , 1992 .
[28] M. Houghton,et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan , 1991 .
[29] M. Clementi,et al. Evolution of Hypervariable Region 1 of Hepatitis C Virus in Primary Infection , 1998, Journal of Virology.
[30] M. Nei,et al. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. , 1986, Molecular biology and evolution.
[31] R H Purcell,et al. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Holland,et al. RNA virus populations as quasispecies. , 1992, Current topics in microbiology and immunology.
[33] H. Thomas,et al. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. , 1994, Gastroenterology.
[34] M. Tong,et al. Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.
[35] H. Alter. To C or not to C: these are the questions. , 1995, Blood.
[36] Giorgio,et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.